RARA CRAFT DATABASE for FDA Medical Devices
510(k)K232586

FDA DEVICE FACTS

Rexious Spinal Fixation System, Statera™ Spinal System, Statera-M™ Spinal System

K&J Consulting Corp.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEOctober 24, 2023PRODUCT CODENKB

Indications for use

The Rexious Spinal Fixation System, Statera™ Spinal System, and Statera - M™ Spinal System are intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of t he following acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine: degenerative disc disease; spondylolisthesis; fracture; dislocation; scoliosis; kyphosis; spinal tumor; and failed previous fusion (pseudarthrosis). When used for posterior non-cervical screw fixation in pediatric patients, the Rexious Spinal Fixation System, Statera ™ Spinal System, and Statera- M™ Spinal System are indicated as an adjunct to fusion to treat: adolescent idiopathic scoliosis, progressive spinal deformities (i.e., scoliosis, kyphosis, or lordosis) including infantile and juvenile idiopathic scoliosis, neuromuscular scoliosis, and congenital scoliosis, spondylolisthesis, spondylolysis, pseudarthrosis, failed prior fusion, and fracture caused b y tumor and/or trauma in pediatric patients. Pediatric pedicle screw fixation is limited to a posterior approach and is intended to be used with autograft and/or allograft. When used as an anterolateral thoracolumbar system, the Rexious Spinal Fixation System, Statera™ Spinal System, and Statera-M™ Spinal System are intended for anterolateral screw (with staples) fixation for the following indications: degenerative disc disease (defined as discogenic back pain with degeneration of the disc confirmed by hi story and radiographic studies), spinal stenosis, spondylolisthesis, spinal deformities (i.e. scoliosis, kyphosis, and/or lordosis), fracture or dislocation of the thoracolumbar spine, pseudoarthrosis, tumor resection, and/or failed previous fusion. Levels of screw fixation are T8-L5. Performance Data: Non-clinical testing was performed to demonstrate that the subject Statera™ Spinal System, and Statera-M™ Spinal System are substantially equivalent to the predicate device. The following testing was performed in accordance with the ASTM F1717:

- Static compression bending

- Dynamic compression bending

- Static Torsion The nonclinical tests demonstrate that th e Statera™ Spinal System, and Statera-M™ Spinal System are substantially equivalent to the legally marketed predicate devices. For the remaining subject devices, submission is on ly transferring name of a system that has already been cleared under K222415. As those subject devices are identical to the p redicate devices, n o performance testing is required. Predicate Device: Primary predicate: Dio Medical - Rexious Spinal Fixation System (K222415) Additional predicates: Globus Medical – Revere Stabilization System (K133350)

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 17, 2026